NC
Nexthera Capital Portfolio holdings
AUM
$120M
This Quarter Return
+39.41%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$82.4M
AUM Growth
+$82.4M
(-46%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-140.62%
Top 10 Holdings %
Top 10 Hldgs %
72.4%
Holding
34
New
12
Increased
–
Reduced
12
Closed
8
Top Buys
| 1 |
UroGen Pharma
URGN
|
$4.9M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$3.09M |
| 3 |
Sarepta Therapeutics
SRPT
|
$2.54M |
| 4 |
uniQure
QURE
|
$2.31M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.12M |
Top Sells
| 1 |
Novartis
NVS
|
$22.9M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$20M |
| 3 |
Insmed
INSM
|
$16.1M |
| 4 |
Bausch Health
BHC
|
$11.3M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$10.8M |
Sector Composition
| 1 | Healthcare | 92.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MediWound
MDWD
$182M
| – | – |
-104,546
| Closed | -$424K |
|
27
Sutro Biopharma
STRO
$72.7M
| – | – |
-249,496
| Closed | -$2.25M |
|
28
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
0
| – | – |
|
29
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
VCNX
30
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| – | – |
-17,047
| Closed | -$62K |
|
|
RVLP
31
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| – | – |
-120,620
| Closed | -$935K |
|
|
ATNX
32
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-123,305
| Closed | -$1.57M |
|
|
ZSAN
33
DELISTED
Zosano Pharma Corporation
ZSAN
| – | – |
-798,719
| Closed | -$1.69M |
|
|
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-396,198
| Closed | -$7.74M |
|